After Hours
$
47.96
Change
+0.45 +0.95%
Volume
Volume 3,696
Mar 5, 2021, 7:41 p.m.
Quotes are delayed by 20 min
Previous close
$ 46.91
$ 47.51
Change
+0.60 +1.28%
Day low
Day high
$40.69
$48.19

52 week low
52 week high
$13.90
$86.03

Market cap
$3.14B
Average volume
977,553
P/E ratio
N/A
Rev. per Employee
$367,134
EPS
-0.67
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on VCYT
-
Veracyte started at buy with $61 stock price target at Truist
- Tomi Kilgore
-
Veracyte started at sector weight with $48 stock price target at KeyBanc Capital
- Tomi Kilgore
-
Experts Talk Therapies and Stocks at Barron’s Biotech Breakfast
- Barron's Online
-
Veracyte downgraded to neutral from buy at Janney
- Tomi Kilgore
-
Veracyte upgraded to buy from neutral at Janney Montgomery Scott
- Tomi Kilgore
Analyst Ratings
-
Benzinga's Top Upgrades, Downgrades For November 7, 2017
- Benzinga.com
-
- Benzinga.com
-
- Benzinga.com
Other News on VCYT
-
Veracyte: Not Too Excited After Momentum Run
- Seeking Alpha
-
Veracyte, Inc. 2020 Q4 - Results - Earnings Call Presentation
- Seeking Alpha
-
Veracyte secures $550M via equity raise
- Seeking Alpha
-
Veracyte to acquire Decipher Biosciences
- Seeking Alpha
-
Veracyte (VCYT) in Focus: Stock Moves 7% Higher
- Zacks.com
-
Veracyte announces new preliminary data for lung cancer tests
- Seeking Alpha
-
Veracyte, Inc. 2020 Q3 - Results - Earnings Call Presentation
- Seeking Alpha
-
- Edgar Online - (EDG = 10Q, 10K)
-
Veracyte EPS beats by $0.12, beats on revenue
- Seeking Alpha
- Loading more headlines...
Press Releases on VCYT
-
Should Investors Be Watching These Top Biotech Stocks This Month?
- StockMarket.com
-
Veracyte to Present at 10th Annual SVB Leerink Global Healthcare Conference
- BusinessWire - BZX
-
Veracyte Announces Fourth Quarter and Full-Year 2020 Financial Results
- BusinessWire - BZX
-
Veracyte, Inc. to Host Earnings Call
- ACCESSWIRE
-
Veracyte Announces Proposed Public Offering of Common Stock
- BusinessWire - BZX
-
Veracyte to Acquire Decipher Biosciences
- BusinessWire - BZX
-
Veracyte Announces Preliminary Fourth Quarter and Full-Year 2020 Financial Results
- BusinessWire - BZX
-
Veracyte to Participate in 23rd Annual Needham Virtual Growth Conference
- BusinessWire - BZX
-
Bayer and Veracyte Announce Precision Oncology Collaboration in Thyroid Cancer
- BusinessWire - BZX
-
Bayer and Veracyte Announce Precision Oncology Collaboration in Thyroid Cancer
- BusinessWire - BZX
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com